Erastapex Plus 20 mg / 12.5 mg 30 tablets

Tradename

Erastapex plus

Erastapex plus

Composition

One tablet contains:

Olmesartan medoxomil 20 mg

Hydrochlorothiazide 12.5 mg

Auxiliary components:

Lactose, colodial silicone dioxide, starch, magnesium stearate, talc, titanium dioxide.

Properties

Erastapex plus is a combination drug that includes an angiotensin II receptor antagonist (olmesartan medoxomil) and a thiazide diuretic (hydrochlorothiazide). The combination of two active substances has a combined antihypertensive effect, as a result of which blood pressure decreases to a greater extent than when each of them is taken separately. When taking the drug once a day, an effective and uniform decrease in blood pressure is achieved within 24 hours.

Indications

— essential arterial hypertension (with the ineffectiveness of olmesartan medoxomil monotherapy).

Method of administration and dosage:

The recommended dose is 1 tablet per day.

Contraindications

— hereditary lactose intolerance, lack of lactase in the body or malabsorption syndrome of glucose and lactose;

-severe liver dysfunction (more than 9 points on the Child-Pugh scale) (risk of developing hepatic coma), obstruction of the biliary tract and cholestasis;

-severe renal dysfunction (CC less than 30 ml / min.);

Side effects

From the side of the central nervous system:

Often: dizziness.

Uncommon: syncope.